Operational Precision Oncology

Definition

Operational precision oncology extends personalized cancer care beyond tumor biology and genomics to whether a specific treatment, trial, schedule, location, and delivery format can work in the circumstances of a patient’s life.

Current Synthesis

Scientific matching is only part of personalization. A molecularly appropriate trial may be unusable when travel, frequency, mobility, caregiving, cost, or treatment format makes participation infeasible. Operational context should therefore shape the option set before clinician and patient judgment, without letting convenience silently replace medical benefit or informed preference.

Key Claims

• Precision oncology includes logistics and feasibility alongside genetics, response data, and similar cases.
• Automated trial matching can search eligibility criteria that no clinician can reliably remember across many studies.
• Treatment format and visit frequency can determine whether an option is usable for a particular patient.
• Care coordination must carry patient circumstances across clinicians, schedulers, nurses, and information systems.
• AI can organize options and constraints, but clinicians and patients remain responsible for the final choice.

Evidence

Trial and treatment matching

• EP 26: The Future of Healthcare - AI, Data and Human Touch presents trial matching as an established automation opportunity in a field with too many changing criteria for unaided recall.

Patient feasibility

• EP 26: The Future of Healthcare - AI, Data and Human Touch contrasts weekly infusion with an oral standard-of-care option for a lung-cancer patient who cannot drive.

Coordination context

• EP 26: The Future of Healthcare - AI, Data and Human Touch shows how a patient’s planned absence can be lost between conversation and scheduling, disrupting treatment operations.

Counterevidence & Qualifications

• Feasibility should not become a proxy for denying more effective care or excluding patients from trials that could provide support.
• The source gives illustrative cases rather than comparative evidence that AI matching improves enrollment, outcomes, equity, or adherence.
• Patient circumstances and preferences change; captured context needs confirmation rather than automatic reuse.
• Logistics, genomics, comorbidity, benefit-risk evidence, patient preference, and clinician judgment may conflict and require explicit tradeoffs.

What Changed

• Established the concept from EP26’s broader account of personalized oncology.

Related Concepts

• AI Clinical Validation In Drug Discovery - supplies the clinical-evidence boundary that operational precision must preserve.
• Healthcare AI Infrastructure - supports searches across changing eligibility criteria and care context.
• Ambient Oncology - captures and coordinates practical patient context across workflows.
• Human Judgment Under AI - retains clinician and patient authority over treatment choices.
• Outpatient Care Continuity and Handoff / 门诊连续性与交接 - adjacent coordination problem across care touchpoints and handoffs.